Waldencast Acquisition Corp. Warrants logo

Waldencast Acquisition Corp. Warrants (WALDW)

Market Closed
11 Jun, 20:00
NASDAQ (CM) NASDAQ (CM)
$
0. 05
-0.01
-9.4915%
Pre Market
$
0. 06
+0.01 +12.3596%
6.81M Market Cap
- P/E Ratio
- Div Yield
2,861 Volume
0 Eps
$ 0.06
Previous Close
Investors:
Add Transaction
Day Range
0.05 0.06
Year Range
0.02 0.86
Want to track WALDW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

WALDW closed today lower at $0.05, a decrease of -9.4915% from yesterday's close, completing a monthly decrease of -16.5625% or -$0.01. Over the past 12 months, WALDW stock gained 33.5%.
WALDW is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

WALDW Chart

People also search for

Fingermotion Inc.
$ 0.6
-4.825%
SuperCom Ltd.
$ 10.03
+3.7229%
Viewbix Inc.
$ 4.52
+6.1033%
CCG
Cheche Group Inc.
$ 0.49
+2.5157%
Lotus Technology Inc.
$ 0.06
-6.3768%

Waldencast Acquisition Corp. Warrants Investors

Name Quantity Cost Value Profit ($) Gain (%)
BO
Brian Oliveira Clear Street Group Inc.
472,128 $18,421.27 $23,606.4 $5,185.13 28.15%
LV
Lindsay Voak Greenland Capital Management LP
30,799 $1,139.57 $1,539.95 $400.38 35.13%

Waldencast Acquisition Corp. Warrants (WALDW) FAQ

What is the stock price today?

The current price is $0.05.

On which exchange is it traded?

Waldencast Acquisition Corp. Warrants is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is WALDW.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 6.81M.

Has Waldencast Acquisition Corp. Warrants ever had a stock split?

No, there has never been a stock split.

Waldencast Acquisition Corp. Warrants Profile

Software Industry
Information Technology Sector
Michel Brousset CEO
NASDAQ (CM) Exchange
G9503X111 CUSIP
US Country
335 Employees
- Last Dividend
28 Jul 2022 Last Split
11 May 2021 IPO Date

Overview

Waldencast Acquisition Corp. is a prominent entity in the skincare industry, primarily known for its innovative approach to advanced skincare treatments. Established in 1988 and based in White Plains, New York, the company has carved a niche for itself by focusing on products that combat the signs of premature skin aging, damage due to sun exposure, hyperpigmentation, acne, and other skin concerns. These products are widely available and endorsed by dermatologists, plastic surgeons, medical spas, and skincare professionals, ensuring they reach those in need of professional-grade skincare solutions.

Products and Services

Waldencast Acquisition Corp. boasts a diverse portfolio through its key brands, Obagi Medical and Obagi Clinical, each designed to cater to specific skin health needs:

  • Obagi Medical: This line is renowned for its transformational skincare products that are specifically formulated to tackle the visible signs of skin aging. Products under Obagi Medical target dark spots, hyperpigmentation, fine lines, and wrinkles, effectively helping to rejuvenate and maintain skin health. In addition to anti-aging properties, these products also focus on enhancing skin tone and texture, offering comprehensive skincare solutions to those looking to maintain youthful, vibrant skin.
  • Obagi Clinical: Tailored for individuals aiming to prevent the early signs of skin aging, Obagi Clinical offers an array of skincare products. These items are meticulously designed to safeguard the skin from potential damage while nurturing it to prevent the onset of wrinkles, fine lines, and other premature aging indicators. Much like its counterpart, Obagi Clinical emphasizes maintaining and enhancing the skin's tone and texture, equipping users with the tools they need for proactive skin care.

Contact Information

Address: 10 Bank Street
Phone: 917 546 6828